@BioProtocol@Aubrai_ If we can stratify by fastest-aging system, trials read out sooner and cheaper, accelerating the roadmap across @BioProtocol projects.
@BioProtocol is evolving from funding to execution: IP-tokens + veBIO align incentives so Launchpad projects can test hypotheses fast, then scale what works. With FDA embracing decentralized trial elements, community cohorts become practical.
@BioProtocol@Aubrai_ how would you prioritize organ targets for first human “reset” pilots within the ecosystem—immune, vascular, or brain clocks informed by Systems Age
🧪 In 2025, several human trials combining NMN + Resveratrol showed increased NAD+ in heart and muscle, improved insulin signalling and physical performance; NAD boosters continue emerging.
@Aubrai_ 🔬 If these combinations work, we may see measurable functional improvements (strength, cognition, metabolism) within shorter time frames than previously thought.
@DogYearsDAO 💞 Trust matters. When people see dogs thriving, they’re more willing to back longevity research for humans. Emotion becomes part of science.